Table 1.
Melanoma patients (n=50) | Control group (n=54) | |
---|---|---|
Inhibitory KIR | ||
2DL1 | 90.0 | 90.7 |
2DL2 | 54.0 | 50.0 |
2DL3 | 90.0 | 90.7 |
3DL1 | 90.0 | 90.7 |
3DL2 | 100 | 100 |
Activating KIR | ||
2DS1 | 38.0 | 37.0 |
2DS2 | 56.0 | 53.7 |
2DS3 | 32.0 | 27.8 |
2DS4 | 94.0 | 96.3 |
3DS1 | 34.0 | 38.9 |
KIR genotype | ||
AA | 50.0 | 50.0 |
AB | 42.0 | 40.7 |
BB | 8.0 | 9.3 |